Cholesterol modulates the physiological response to nanoparticles by changing the composition of protein corona – Nature Nanotechnology

Quesada-Gonzalez, D. & Merkoci, A. Nanomaterial-based devices for point-of-care diagnostic applications. Chem. Soc. Rev. 47, 4697–4709 (2018).

Article  CAS  Google Scholar 

Irvine, D. J. & Dane, E. L. Enhancing cancer immunotherapy with nanomedicine. Nat. Rev. Immunol. 20, 321–334 (2020).

Article  CAS  Google Scholar 

Stater, E. P., Sonay, A. Y., Hart, C. & Grimm, J. The ancillary effects of nanoparticles and their implications for nanomedicine. Nat. Nanotechnol. 16, 1180–1194 (2021).

Article  CAS  Google Scholar 

Guerrini, G., Magrì, D., Gioria, S., Medaglini, D. & Calzolai, L. Characterization of nanoparticles-based vaccines for COVID-19. Nat. Nanotechnol. 17, 570–576 (2022).

Article  CAS  Google Scholar 

Gadekar, V. et al. Nanomedicines accessible in the market for clinical interventions. J. Control. Release 330, 372–397 (2021).

Article  CAS  Google Scholar 

Thi, T. T. H. et al. Lipid-based nanoparticles in the clinic and clinical trials: from cancer nanomedicine to COVID-19 vaccines. Vaccines 9, 359 (2021).

Article  CAS  Google Scholar 

Monopoli, M. P., Åberg, C., Salvati, A. & Dawson, K. A. Biomolecular coronas provide the biological identity of nanosized materials. Nat. Nanotechnol. 7, 779–786 (2012).

Article  CAS  Google Scholar 

Ren, J. et al. Chemical and biophysical signatures of the protein corona in nanomedicine. J. Am. Chem. Soc. 144, 9184–9205 (2022).

Article  CAS  Google Scholar 

Latreille, P.-L. et al. Scratching the surface of the protein corona: challenging measurements and controversies. ACS Nano 16, 1689–1707 (2022).

Article  CAS  Google Scholar 

Li, M. et al. Nanoparticle elasticity affects systemic circulation lifetime by modulating adsorption of apolipoprotein A-I in corona formation. Nat. Commun. 13, 4137 (2022).

Article  CAS  Google Scholar 

Kamaly, N. Nanoparticle protein corona evolution: from biological impact to biomarker discovery. Nanoscale 14, 1606–1620 (2022).

Article  CAS  Google Scholar 

Ju, Y. et al. Person-specific biomolecular coronas modulate nanoparticle interactions with immune cells in human blood. ACS Nano 14, 15723–15737 (2020).

Article  CAS  Google Scholar 

Hajipour, M. J., Laurent, S., Aghaie, A., Rezaee, F. & Mahmoudi, M. Personalized protein coronas: a ‘key’ factor at the nano-bio interface. Biomater. Sci. 2, 1210–1221 (2014).

Article  CAS  Google Scholar 

Shannahan, J. H. et al. From the cover: disease-induced disparities in formation of the nanoparticle-biocorona and the toxicological consequences. Toxicol. Sci. 152, 406–416 (2016).

Article  CAS  Google Scholar 

Ren, J. et al. Precision nanomedicine development based on specific opsonization of human cancer patient-personalized protein coronas. Nano Lett. 19, 4692–4701 (2019).

Article  CAS  Google Scholar 

Lazarovits, J. et al. Synthesis of patient-specific nanomaterials. Nano Lett. 19, 116–123 (2019).

Article  CAS  Google Scholar 

Di Santo, R. et al. Personalized graphene oxide-protein corona in the human plasma of pancreatic cancer patients. Front. Bioeng. Biotechnol. 8, 491 (2020).

Article  Google Scholar 

Chetwynd, A. J. & Lynch, I. The rise of the nanomaterial metabolite corona, and emergence of the complete corona. Environ. Sci. Nano 7, 1041–1060 (2020).

Article  CAS  Google Scholar 

Raesch, S. S. et al. Proteomic and lipidomic analysis of nanoparticle corona upon contact with lung surfactant reveals differences in protein, but not lipid composition. ACS Nano 9, 11872–11885 (2015).

Article  CAS  Google Scholar 

Braccia, C. et al. The lipid composition of few layers graphene and graphene oxide biomolecular corona. Carbon 185, 591–598 (2021).

Article  CAS  Google Scholar 

Liu, K., Salvati, A. & Sabirsh, A. Physiology, pathology and the biomolecular corona: the confounding factors in nanomedicine design. Nanoscale 14, 2136–2154 (2022).

Article  CAS  Google Scholar 

Kobos, L. M. et al. An integrative proteomic/lipidomic analysis of the gold nanoparticle biocorona in healthy and obese conditions. Appl. Vitr. Toxicol. 5, 150–166 (2019).

Article  CAS  Google Scholar 

Lima, T., Bernfur, K., Vilanova, M. & Cedervall, T. Understanding the lipid and protein corona formation on different sized polymeric nanoparticles. Sci. Rep. 10, 1129 (2020).

Article  CAS  Google Scholar 

Tavakol, M. et al. Disease-related metabolites affect protein-nanoparticle interactions. Nanoscale 10, 7108–7115 (2018).

Article  CAS  Google Scholar 

Luo, J., Yang, H. & Song, B. L. Mechanisms and regulation of cholesterol homeostasis. Nat. Rev. Mol. Cell Biol. 21, 225–245 (2020).

Article  CAS  Google Scholar 

Civeira, F., Arca, M., Cenarro, A. & Hegele, R. A. A mechanism-based operational definition and classification of hypercholesterolemia. J. Clin. Lipidol. 16, 813–821 (2022).

Article  Google Scholar 

Kim, S. H. et al. Understanding the biomolecular coronas of high-density lipoproteins on pegylated Au nanoparticles: implication for lipid corona formation in the blood. ACS Appl. Nano Mater. 5, 2018–2028 (2022).

Article  CAS  Google Scholar 

Kim, H., Kumar, S., Kang, D. W., Jo, H. & Park, J. H. Affinity-driven design of cargo-switching nanoparticles to leverage a cholesterol-rich microenvironment for atherosclerosis therapy. ACS Nano 14, 6519–6531 (2020).

Article  CAS  Google Scholar 

Fu, Q., Yu, L., Wang, Y., Li, P. & Song, J. Biomarker-responsive nanosystems for chronic disease theranostics. Adv. Funct. Mater. 33, 2206300 (2023).

Article  CAS  Google Scholar 

Kim, K. R., Kim, J., Back, J. H., Lee, J. E. & Ahn, D. R. Cholesterol-mediated seeding of protein corona on dna nanostructures for targeted delivery of oligonucleotide therapeutics to treat liver fibrosis. ACS Nano 16, 7331–7343 (2022).

Article  CAS  Google Scholar 

Dreaden, E. C., Alkilany, A. M., Huang, X., Murphy, C. J. & El-Sayed, M. A. The golden age: gold nanoparticles for biomedicine. Chem. Soc. Rev. 41, 2740–2779 (2012).

Article  CAS  Google Scholar 

Kim, S. E. et al. Ultrasmall nanoparticles induce ferroptosis in nutrient-deprived cancer cells and suppress tumour growth. Nat. Nanotechnol. 11, 977–985 (2016).

Article  CAS  Google Scholar 

Ke, P. C., Lin, S., Parak, W. J., Davis, T. P. & Caruso, F. A decade of the protein corona. ACS Nano 11, 11773–11776 (2017).

Article  CAS  Google Scholar 

Xiao, Q. et al. The effects of protein corona on in vivo fate of nanocarriers. Adv. Drug Deliv. Rev. 186, 114356 (2022).

Article  CAS  Google Scholar 

Blanco, E., Shen, H. & Ferrari, M. Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat. Biotechnol. 33, 941–951 (2015).

Article  CAS  Google Scholar 

Macia, E. et al. Dynasore, a cell-permeable inhibitor of dynamin. Dev. Cell 10, 839–850 (2006).

Article  CAS  Google Scholar 

Francia, V. et al. Corona composition can affect the mechanisms cells use to internalize nanoparticles. ACS Nano 13, 11107–11121 (2019).

Article  CAS  Google Scholar 

Lara, S. et al. Identification of receptor binding to the biomolecular corona of nanoparticles. ACS Nano 11, 1884–1893 (2017).

Article  CAS  Google Scholar 

Ngo, W. et al. Identifying cell receptors for the nanoparticle protein corona using genome screens. Nat. Chem. Biol. 18, 1023–1031 (2022).

Article  CAS  Google Scholar 

Benetti, F., Bregoli, L., Olivato, I. & Sabbioni, E. Effects of metal (loid)-based nanomaterials on essential element homeostasis: the central role of nanometallomics for nanotoxicology. Metallomics 6, 729–747 (2014).

Article  CAS  Google Scholar 

Ashkarran, A. A. et al. Measurements of heterogeneity in proteomics analysis of the nanoparticle protein corona across core facilities. Nat. Commun. 13, 6610 (2022).

Article  CAS  Google Scholar 

Sheibani, S. et al. Nanoscale characterization of the biomolecular corona by cryo-electron microscopy, cryo-electron tomography, and image simulation. Nat. Commun. 12, 573 (2021).

Article  CAS  Google Scholar 

Shevchenko, A., Tomas, H., Havlis, J., Olsen, J. V. & Mann, M. In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat. Protoc. 1, 2856–2860 (2006).

Article  CAS  Google Scholar 

Cao, Z. T. et al. Protein binding affinity of polymeric nanoparticles as a direct indicator of their pharmacokinetics. ACS Nano 14, 3563–3575 (2020).

Article  CAS  Google Scholar 

Hess, B. P-LINCS: a parallel linear constraint solver for molecular simulation. J. Chem. Theory Comput. 4, 116–122 (2008).

Article  CAS  Google Scholar